Frances Creek barium sulfate project
F3 Uranium Reports High-Grade Results at JR Zone, Highlighting Growth Potential in the Athabasca Basin
F3 Uranium Corp. (TSXV: FUU) (OTCQB: FUUFF) has just announced assay results for drill hole PLN24-176 from its…
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
-
Brent Willis on Voyageur Pharmaceuticals’ Shift to Innovative Barium Contrast Formulations and an FDA Update
September 17, 2024 — In a recent interview with InvestorNews host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, September 12, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, September 12th, at 9 AM EST,…
No CommentsRaj Shah
-
Voyageur’s Partnership with Rain Cage Offers the Promise of Transforming Diagnostic Imaging and Healthcare Solutions
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development Voyageur Pharmaceuticals Ltd. (TSXV: VM)…
No CommentsInvestorNews
-
Brent Willis on Voyageur’s ambition to revolutionize radiology by vertically integrating the barium and iodine contrast market
June 3, 2024 — InvestorNews host Pat Bolland interviews Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
-
Voyageur Pharmaceutical’s Brent Willis on Revolutionizing the Medical Imaging Industry, plus SmoothX
In a revealing interview on Investor.Coffee, host Tracy Weslosky engages in an enlightening conversation with Brent Willis, President,…
No CommentsInvestorNews
-
Brent Willis on Voyageur Pharmaceuticals’ competitive suite of barium radiographic contrast media products
In a recent InvestorIntel interview, Chris Thompson speaks with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd.…
No CommentsInvestorNews
Top 10 Trending
-
The War for Critical Minerals and Capital Resources: Technology Metals on the Front Lines of Global Power
-
American Rare Earths’ Chris Gibbs on Accelerating the Halleck Creek Critical Minerals Project in Wyoming
-
Michel Pepin on Ciscom Corp.’s Strong Q3 Growth and Expanded Acquisition Strategy in ICT Sector
IN8 Member News
-
NEO Battery Materials Confirms Stable and Unaffected Operations Amid South Korea’s Declaration of Emergency Martial Law
-
Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
-
NEO Battery Materials Announces Director Resignation and Updates to Upcoming Corporate Webinar
-
F3 Hits 4.5m of 50.1% U3O8 Within 30.9% Over 7.5m at JR
-
Panther Metals PLC: Resourcing Tomorrow and Presentation
